Jefferies Maintains Hold on Moderna, Lowers Price Target to $325

Jefferies analyst Michael Yee maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $375 to $325.

Jefferies analyst Michael Yee maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $375 to $325.

Total
0
Shares
Related Posts